The Effective Statistician - in association with PSI

How the R Consortium Is Transforming Regulatory Submissions and AI in Clinical Trials

Aug 11, 2026
Ning Leng, a statistician trained in computational genetics who led R, Shiny, Git and cloud adoption at Roche/Genentech, discusses how the R Consortium drives collaborative regulatory submission pilots with the FDA. She covers interactive reproducible submissions using Shiny and WebAssembly, containerized workflows, and early pilots exploring generative AI for clinical trials. She also explains how benchmarking and community resources support responsible AI use.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

From Statistician To R Innovation Lead

  • Ning Leng moved from being a statistician into leading an innovation team at Roche Genentech to drive R, cloud, Git, and Shiny adoption.
  • She started an R user community teaching packages, Shiny, and Git which led to a formal adoption strategy and cross-industry work.
INSIGHT

Practical Examples Were The Missing Piece

  • The real barrier to R submissions was lack of practical examples, not FDA policy, since FDA has stated they don't require a specific language.
  • Companies feared FDA rejection, so public mock submissions were created to show traceability and reproducibility with R.
INSIGHT

R Consortium As Cross Industry Collaboration Hub

  • The R Consortium is a nonprofit platform promoting R across industries and hosts working groups that enabled pharma collaboration with the FDA.
  • Active pharma groups include the Submissions Working Group and a Validation Hub producing white papers and quality-metrics tools.
Get the Snipd Podcast app to discover more snips from this episode
Get the app